Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Here's a Basket of Potentially Explosive Growth
Motley Fool
Saturday, January 26, 2013 - 11:51am
tags:
Market Vectors Biotech ETF
BGI-Shenzhen Extends Tender Offer For Complete Genomics, Inc.
Yahoo/PR Newswire
Saturday, January 26, 2013 - 11:50am
tags:
BGI-Shenzhen, Complete Genomics
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, January 26, 2013 - 11:48am
tags:
Pacific Biosciences, Arena Pharmaceuticals, Synergy Pharmaceuticals
It's All Relative for This Biotech Underperformer
Motley Fool
Saturday, January 26, 2013 - 11:47am
tags:
Amgen, Celgene Corporation
Cadence Forecasts Ofirmev Sales
Yahoo/Zacks
Saturday, January 26, 2013 - 11:46am
tags:
Cadence Pharmaceuticals, Ofirmev, pain management
Cytokinetics regains compliance with Nasdaq rules
Yahoo/AP
Saturday, January 26, 2013 - 11:45am
tags:
Cytokinetics
Vivus: Today's Featured Drugs Laggard
The Street
Saturday, January 26, 2013 - 11:45am
tags:
Vivus
Celgene Corporation: Today's Featured Health Care Winner
The Street
Saturday, January 26, 2013 - 11:44am
tags:
Celgene Corporation
Safest Way to Play Biotech
Yahoo/Zacks
Saturday, January 26, 2013 - 11:44am
tags:
A Look at Three Biotech Movers
Motley Fool
Saturday, January 26, 2013 - 11:43am
tags:
Sarepta Therapeutics, Celsion, Threshold Pharmaceuticals
Biogen Idec Third Quarter Earnings Sneak Peek
Wall Street Cheat Street
Saturday, January 26, 2013 - 11:42am
tags:
Biogen Idec, earnings
Pfizer's Success Plan: Streamline Business And Introduce New Drugs
Seeking Alpha
Friday, January 25, 2013 - 11:59am
tags:
Pfizer, Novartis
A.P. Pharma: PDUFA Date On APF530 Looms And I Am A Buyer
Seeking Alpha
Friday, January 25, 2013 - 11:58am
tags:
AP Pharma, APF530
Eli Lilly & Co Fourth Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Friday, January 25, 2013 - 11:57am
tags:
Eli Lilly, earnings
FDA OKs over-the-counter version of Merck overactive bladder drug
Reuters
Friday, January 25, 2013 - 11:57am
tags:
FDA, Merck, overactive bladder, Oxytrol
The Big Gamble of CETP Inhibitors Comment Now Follow Comments
Forbes
Friday, January 25, 2013 - 11:05am
tags:
CETP inhibitors, Merck, Anacetrapib, Torcetrapib, Pfizer, Roche, dalceptrapib
Should Gilead's quad pill get an exclusivity extension from FDA?
Fierce Pharma
Friday, January 25, 2013 - 10:44am
tags:
Quad, Gilead, FDA, HIV
Novartis Board Was Shocked by Vasella’s Decision to Leave
Bloomberg
Friday, January 25, 2013 - 10:43am
tags:
Novartis, Daniel Vasella
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Friday, January 25, 2013 - 10:39am
tags:
Vivus, Theravance, Roche, MAP Pharmaceuticals, M&A, Immunogen, GSK, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Allergan
Novartis Under U.S. Investigation for Tekturna Marketing
Bloomberg
Friday, January 25, 2013 - 10:13am
tags:
Novartis, Tekturna

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.